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Microbial bioﬁlms are particularly resistant to antimicrobial therapies. These surface-
attached communities are protected against host defenses and pharmacotherapy by
a self-produced matrix that surrounds and fortiﬁes them. Recent proteomic evidence
also suggests that some bacteria, including the opportunistic pathogen Pseudomonas
aeruginosa, undergo modiﬁcations within a bioﬁlm that make them uniquely resistant
compared to their planktonic (free-living) counterparts. This study examines 50 proteins
in the resistance subproteome of both surface-associated and free-living P. aeruginosa
PAO1 over three time points. Proteins were grouped into categories based on their roles
in antimicrobial: (i) binding, (ii) efﬂux, (iii) resistance, and (iv) susceptibility. In addition,
the extracellular outer membrane vesicle-associated proteome is examined and compared
between the two growth modes. We show that in whole cells between 12–24% of the
proteins are present at signiﬁcantly different abundance levels over time, with some
proteins being unique to a speciﬁc growthmode; however, the total abundance levels in the
four categories remain consistent. In contrast, marked differences are seen in the protein
content of the outer membrane vesicles, which contain a greater number of drug-binding
proteins in vesicles puriﬁed from late-stage bioﬁlms. These results show how the method
of analysis can impact the interpretation of proteomic data (i.e., individual proteins vs.
systems), and highlight the advantage of using protein-based methods to identify potential
antimicrobial resistance mechanisms in extracellular sample components. Furthermore,
this information has the potential to inform the development of speciﬁc antipseudomonal
therapies that quench possible drug-sequestering vesicle proteins.This strategy could serve
as a novel approach for combating the high-level of antimicrobial resistance in P. aeruginosa
bioﬁlms.
Keywords: proteomics, Pseudomonas aeruginosa, outer membrane vesicles, antimicrobial resistance, bacterial
biofilms
INTRODUCTION
The opportunistic pathogenPseudomonas aeruginosa is a common
agent of infectious disease in immunocompromised individ-
uals (Afessa and Green, 2000; Öncül et al., 2013; Chatterjee
et al., 2014), and is the dominant pathogen in late-stage cys-
tic ﬁbrosis (CF; Rajan and Saiman, 2002; Rudkjobing et al.,
2012). P. aeruginosa has many features that make it intrinsi-
cally resistant to antimicrobial therapies, including a low mem-
brane permeability (Angus et al., 1982; Yoshimura and Nikaido,
1982), and an extensive collection of multidrug efﬂux pumps
(Li et al., 1995, 2003; Poole et al., 1996; Köhler et al., 1997; Morita
et al., 2001; Aendekerk et al., 2002; Chuanchuen et al., 2002; Mima
et al., 2005, 2007, 2009; Figure 1). Additional mechanisms, includ-
ing lipopolysaccharide modiﬁcations (Ernst, 1999; Ernst et al.,
2005; Cigana et al., 2009) and conversion to mucoidy (Lam
et al., 1980), which are established during adaptation to the CF
lung environment, further enhance P. aeruginosa’s recalcitrant
nature (Nichols et al., 1988; Pritt et al., 2007; Needham and Trent,
2013; Figure 1). Ultimately, chronic pulmonary infections in CF
become unyielding to treatment, resulting in high levels of patient
morbidity and mortality.
During infection, P. aeruginosa transitions from an inde-
pendent, free-swimming lifestyle (i.e., planktonic) into sessile
aggregates of bacteria called bioﬁlms. These structures are sur-
rounded by a self-produced extracellular matrix consisting of
proteins, DNA and polysaccharides, which acts as a physical and
physiological barrier against both host-produced and pharma-
ceutical antimicrobials. Some of the protection is provided by
the physical structure of the extracellular matrix, which can limit
penetration (Jefferson et al., 2005) and directly bind some classes
of antibiotics (Gordon et al., 1988; Chiang et al., 2013). A sec-
ond level of protection is provided by the unique physiology
of the bioﬁlm matrix, including metabolic and oxygen gradi-
ents (Anderl et al., 2003; Walters et al., 2003; Wessel et al., 2014).
These gradients reduce the efﬁcacy of drugs that target growth and
metabolic processes (Tuomanen et al., 1986; Walters et al., 2003),
or are affected by anaerobic conditions (Borriello et al., 2004).
In addition, it has been suggested that chromosomally encoded
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FIGURE 1 | Overview of resistance mechanisms in Pseudomonas
aeruginosa. P. aeruginosa have a variety of intrinsic and adaptive
resistance mechanisms including: a highly impermeable membrane,
conversion to mucoidy, active efﬂux of antimicrobials, reduction of outer
membrane porins, lipopolysaccharide (LPS) modiﬁcations, and
modiﬁcation of drug targets. Examples of speciﬁc proteins involved in
these mechanisms include: MexAB-OprM (efﬂux pump), OprD (porin),
ArnA and ArnB (LPS modifying proteins), GyrA (drug target, DNA
metabolic processes), and NagZ (peptidoglycan-based cell wall
biogenesis). See main text for references.
drug-deactivating enzymes may concentrate in the bioﬁlm matrix
and decrease the efﬁcacy of certain antimicrobials, such as beta-
lactams (Anderl et al., 2000; Bagge et al., 2004; Mulet et al., 2011).
Accordingly, experimental systems designed to speciﬁcally chal-
lenge sessile cells with antimicrobials indicate that P. aeruginosa
bioﬁlms require inhibitory concentrations that are often orders
of magnitude higher than those required for planktonic controls
(Ceri et al., 1999).
The question that remains is whether the bacteria themselves
undergo speciﬁc changes within the bioﬁlm that make them more
resistant than their planktonic counterparts. Whiteley et al. (2001)
examined gene expression in a P. aeruginosa PAO1 bioﬁlm using
DNA microarray techniques. Surprisingly, they noted that only
1% of the genes were differentially expressed between plank-
tonic and bioﬁlm cultures, and only a handful of genes had
potential roles in antimicrobial resistance (Whiteley et al., 2001).
More recently, RNA sequencing (Dötsch et al., 2012) and meta-
analysis (Folsom et al., 2010) strategies have investigated if the
transcriptomes of bioﬁlm and planktonic P. aeruginosa provide
any clues to their high level of resistance. These authors gen-
erally concluded that at the transcript level bioﬁlms displayed
expression patterns indicative of oxygen limitation and slowed
metabolism (Folsom et al., 2010; Dötsch et al., 2012). Over-
all, their expression proﬁles showed a considerable amount of
overlap with stationary phase planktonic cultures. Importantly,
no speciﬁc resistance mechanisms were identiﬁed. Though the
lack of ﬁndings related to bioﬁlm resistance in these studies
is unexpected, it is possible that alternate technical approaches
may reveal further insight. Speciﬁcally, early studies using mass
spectrometry (MS)-based approaches demonstrated qualitative
differences in 10–50% of the identiﬁed proteins between P. aerug-
inosa bioﬁlms and planktonic cultures at different time points
(Sauer et al., 2002;Vilain et al., 2004).Whilemechanisms of antibi-
otic resistance were not a focus of these studies, these ﬁndings
do suggest that bioﬁlm-speciﬁc cellular changes may occur at a
post-transcriptional level. Furthermore, by directly comparing
mRNA and protein levels in the same sample, others have found
that (i) the cellular abundance of protein is primarily controlled
at the level of translation (Schwanhäusser et al., 2011); (ii) the
correlation between mRNA and protein abundance within a sin-
gle sample type is often low (Nie et al., 2006; Taniguchi et al.,
2010; Maier et al., 2011; Walley et al., 2013); and (iii) proteins
are more stable and have a greater dynamic range than mRNA
(Schwanhäusser et al., 2011).
Despite 10 years worth of studies it is still unclear if speciﬁc
cellular changes contribute to the increased antibiotic resistance of
P. aeruginosa growing in a bioﬁlm. However, evidence suggests the
examination of the proteomes of planktonic and bioﬁlm cultures
will provide the most accurate molecular description of these cells.
We recently established a MS-based experimental platform and
used spectral counting methods to quantify over 1884 whole cell
proteins in planktonic andbioﬁlmcultures of P. aeruginosa at three
time points during development (Park et al., 2014). This study
demonstrated that ∼9% of the identiﬁed high-quality proteins
were either unique to one of the growth modes, or present at
signiﬁcantly different abundance levels. One of the proteins we
highlighted in this study was GyrA (PA3168). This protein, which
is part of the DNA topoisomerase complex (Winsor et al., 2010), is
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a target of the quinolone class of antibiotics (Wishart et al., 2007)
and was signiﬁcantly less abundant in bioﬁlm cultures at the 48 h
time point (Park et al., 2014).
In this current study we completed a focused examination of
a subset of proteins in our dataset with known roles in antibiotic
resistance.We usedMaxQuant software (Cox andMann, 2008) for
improved identiﬁcation and quantiﬁcation of proteins that were
chosen based on: (i) a Pseudomonas Community Annotation
Project (PCAP) designation of a “Antibiotic resistance and sus-
ceptibility” protein (Winsor et al., 2010; further subdivided into
two separate categories); (ii) efﬂux proteins with gene ontology
(GO; Ashburner et al., 2000) annotations of transporter or porin
activity; and (iii) known drug targets (Winsor et al., 2010). In
addition, we isolated outer membrane vesicles (OMV) from the
cell-free supernatant (CFS) of these cultures and analyzed them
using the sameMS-based platformandMaxQuant software. These
structures have been shown to play a role in bioﬁlm formation
(Yonezawa et al., 2009), toxin packaging and delivery (Kesty et al.,
2004; Bauman and Kuehn, 2009; Bomberger et al., 2009; Haurat
et al., 2011), induction of inﬂammatory responses (Bauman and
Kuehn, 2006; Chatterjee and Chaudhuri, 2013; Jun et al., 2013;
Kim et al., 2013; Park et al., 2013; Thay et al., 2013), cell–cell com-
munication (Berleman and Auer, 2012), and bacterial survival
(Manning and Kuehn, 2011). With this study we aim to deter-
mine the contributions of the whole cell and OMV proteomes
to antibiotic resistance in P. aeruginosa bioﬁlms, and to iden-
tify targets for the development of bioﬁlm-speciﬁc antimicrobial
therapy.
RESULTS
P. aeruginosa PAO1 FORMS STRUCTURED BIOFILMS THAT CONTAIN
OMVs
Pseudomonas aeruginosa grown on agar for 24, 48, or 96 h
were imaged using scanning electron microscopy (SEM). A
representative image from the 24 h samples showed evidence
of bioﬁlm structures and maturation based on the organiza-
tion of clusters of individual bacteria connected by a mesh of
dehydrated extracellular matrix material (Figure 2A). OMVs
were observed at the surface of the cells (Figure 2A, inset),
and could be isolated from the CFS of a 24 h bioﬁlm cul-
ture (Figure 2B). The OMVs were similar to those previ-
ously described for PAO1 cultures (Schooling and Beveridge,
2006; Murphy et al., 2014) and were comprised of a single
membrane layer and are present in a range of sizes (∼20–
200 nm).
BIOFILM WHOLE CELLS AND OMVs SHOW DISTINCT PATTERNS OF
INDIVIDUAL PROTEIN ABUNDANCE OVER TIME
Heat maps representing protein abundance show a substantial
amount of variation between bioﬁlm and planktonic samples at
the individual protein level over the three time points examined
(Figure 3). Speciﬁcally, 14, 24, and 12% of the select group of 50
whole cell proteins had signiﬁcantly different abundance levels in
the 24, 48, and 96 h samples (p < 0.05), respectively (Figure 3A).
Similar numbers of proteins were more (8) or less (10) abundant
in bioﬁlms compared to planktonic whole cells. While efﬂux pro-
teins showed a mixed pattern of abundance, the PCAP resistance
FIGURE 2 | Pseudomonas aeruginosa biofilms contain densely packed
whole cells, self-produced matrix material, and extracellular outer
membrane vesicles (OMVs). (A) Scanning electron micrographs of P.
aeruginosa PAO1 grown on tryptic soy agar for 24 h. Dashed box indicates
area of magniﬁcation. Scale bars represent 30 μm (main) and 3 μm (inset).
Inset symbols:White arrowheads indicate OMVs on the surface of whole
cells. Black arrowheads indicate dehydrated extracellular matrix material.
(B)Transmission electron micrograph of negatively stained OMVs puriﬁed
from a 24 h P. aeruginosa bioﬁlm. Scale bar represents 1 μm.
(PCAP-R) proteins (higher in bioﬁlms) and drug targets (lower in
bioﬁlms), were more consistently affected. Intriguingly, the efﬂux
group of proteins seemed to be the most affected by the age of the
bioﬁlm, with higher levels of efﬂux proteins at 24 h, and lower lev-
els at 96 h (vs. time-matched planktonic controls). Furthermore,
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FIGURE 3 | Individual protein abundance data suggest differential
antibiotic resistance strategies in Pseudomonas aeruginosa biofilms
over time. Heat maps representing average protein abundance in whole cell
(A) and OMV (B) replicates with warm colors depicting higher mass
spectrometry intensity values. Proteins were separated into functional
categories relevant to antimicrobial resistance (see “Materials and Methods”
for details). Symbols: “>,” bioﬁlm protein abundance is signiﬁcantly greater
than time- and sample type-matched planktonic controls (e.g., 24 h bioﬁlm
whole cells vs. 24 h planktonic whole cells; p < 0.05); “<,” bioﬁlm protein
abundance is signiﬁcantly less than time- and sample type-matched
planktonic controls (p < 0.05); * and # denotes categories where a speciﬁc
system or drug is listed for the protein, respectively. F, ﬂuoroquinolones; M,
macrolides; NA, none available; ND, not detected, gray boxes; PCAP-R,
PCAP-resistance; PCAP-S, PCAP-susceptibility; PG, peptidoglycan.
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efﬂux proteins belonging to the same complex behaved in similar
ways. For example, both MexH and MexI of the MexGHI-OpmD
pump (Aendekerk et al., 2002) were increased in early bioﬁlm
whole cell samples. Similar to whole cells, bioﬁlm and planktonic
OMVs showed unique protein abundance patterns with 6, 22, and
32% of the select group of proteins having signiﬁcantly differ-
ent abundance levels in the 24, 48, and 96 h samples (p < 0.05),
respectively (Figure 3B). In contrast to the whole cells, the dif-
ferentially abundant proteins were almost exclusively higher in
bioﬁlm OMVs (20/21) across all categories and time points. Over-
all, fewer proteins were detected in planktonic OMV samples (10
of 50).
BIOFILM AND PLANKTONIC CULTURES CONTAIN POOLS OF SHARED
AND EXCLUSIVE PROTEINS
Venn diagrams were used to compare the overlapping and unique
proteins in the various replicate groups. At the highest level, com-
paring the distribution of all 50 proteins in bioﬁlm and planktonic
samples (whole cells and OMVs combined), 60% of the proteins
were detected in both growth modes, with the remaining pro-
portion belonging predominantly to the bioﬁlm samples (30% of
the total; Figure 4A). The majority of the proteins exclusive to
the bioﬁlm samples were efﬂux proteins (11/15), although one
speciﬁc transport protein, PA1238, was exclusive to planktonic
samples. No drug targets were exclusively detected in bioﬁlms;
however, the type III secretion protein PcrV (PA1706), which
is the target of an engineered human antibody Fab fragment
KB001 (Baer et al., 2009), was only detected in planktonic sam-
ples. When whole cells sample groups (24 h, 48 h, and 96 h
replicates combined) were compared (Figure 4B), a similar per-
cent of the total protein proﬁle was shared (∼63%), although
the remaining exclusive proteins were equally distributed between
bioﬁlm and planktonic whole cell samples. Importantly, despite
having equal counts of exclusive proteins, the functional distri-
bution of the proteins was not equal. Similar to above, bioﬁlm
whole cells had greater numbers of unique efﬂux proteins, and
lacked unique drug targets. In direct contrast to the whole cells,
the OMV samples (24, 48, and 96 h replicates combined) had a
much smaller pool of shared proteins (∼30%), and no unique
proteins were detected in the planktonic OMVs (Figure 4C).
Strikingly, 7 of the 24 proteins that were exclusive to bioﬁlm
OMVs were drug targets. When whole cells and OMVs were com-
pared (Figures 4D,E), major differences were noted: (i) bioﬁlm
whole cells and OMVs had a larger pool of shared proteins
(24 vs. 10 in planktonic); (ii) bioﬁlm OMVs contained a much
higher number of the 50 antibiotic resistance and susceptibility
proteins (34 vs. 10 in planktonic OMVs); and (iii) planktonic
OMVs did not contain any unique proteins (vs. planktonic whole
cell). Furthermore, one speciﬁc drug target, penicillin-binding
protein 1B (mrcB, PA4700), was below the level of detection in
bioﬁlm whole cells, but was highly abundant in bioﬁlm OMVs
(Figure 4D).
FUNCTIONAL SUMMARIES INDICATE THAT BIOFILM AND PLANKTONIC
OMVs ARE MORE DISSIMILAR THAN MATCHED WHOLE CELLS
Following individual protein analysis, a systems approach was
taken, and the total protein abundance in each functional category
was compared between replicate groups (Figure 5). Interestingly,
none of the category totals for whole cells were signiﬁcantly dif-
ferent when compared between growth modes within time points
(i.e., bioﬁlm vs. time-matched planktonic) or between time points
within growthmodes (e.g., 24 h bioﬁlmwhole cells vs. 48 h bioﬁlm
whole cells; Figures 5A,B). Furthermore, the net resistance esti-
mate (i.e., resistance categories-susceptibility categories) failed to
reveal anydrastic changes in thewhole cell samples (Figures 5A,B).
In direct contrast, two of the categories showed signiﬁcant dif-
ferences in the OMV samples (Figures 5C,D). Speciﬁcally, at
the 48 h time point, the total abundance of efﬂux proteins in
bioﬁlmOMVs (48-BV)was statistically greater than time-matched
planktonic controls (48-PV; p < 0.05). In addition, OMVs har-
vested from 96 h bioﬁlms (96-BV) were signiﬁcantly enriched
in drug targets compared to 96 h planktonic OMVs (96-PV).
This prominent identiﬁcation of drug targets in bioﬁlm OMVs
was also signiﬁcantly affected by the age of the culture, as the
total amount increased as a function of time (Figure 5C); specif-
ically, the levels were signiﬁcantly higher at 48 h compared to
24 h (p < 0.05), and signiﬁcantly higher in 96 h compared to
48 h (p < 0.05). No time-dependent changes were detected in
total categorical-abundance within the planktonic OMV samples
(Figure 5D).
DISCUSSION
A clear demonstration of a bioﬁlm-speciﬁc gene expression or
protein proﬁle that contributes to adaptive antimicrobial resis-
tance has remained elusive (Drenkard, 2003; Fernandez and
Hancock, 2012). This study examined the proteome of the
model bioﬁlm former P. aeruginosa, and compared the abun-
dance levels of 50 antibiotic resistance and susceptibility proteins
(i.e., the resistance subproteome) between bioﬁlm and plank-
tonic cultures at three time points. Herein, we demonstrate the
effect of individual proteins vs. systems analysis on the inter-
pretation of proteomic data, and highlight the beneﬁts of each
strategy.
Examination of individual whole cell protein quantities over
time showed that on average ∼16% of the bioﬁlm resistance sub-
proteome was differentially abundant compared to planktonic
controls. The size of the effect agrees with early studies that
demonstrate a greater response rate using MS-based strategies
(Sauer et al., 2002; Southey-Pillig et al., 2005) compared to tran-
scriptomics (Whiteley et al., 2001; Folsom et al., 2010). We show
that while PCAP-R proteins and drug targets were consistently
altered in bioﬁlm whole cells (increased and decreased, respec-
tively), efﬂux proteins showed heterogeneous patterns depending
on the individual protein and time point. Speciﬁcally, the pro-
teins MexA and MexB, of the efﬂux pump MexAB-OprM, were
signiﬁcantly lower in bioﬁlm replicates (vs. planktonic) at both
48 h and 96 h (Figure 3A). While this may seem counterintuitive
considering the prominence of this system in previous antibiotic
resistance studies (Li et al., 1995; Srikumar et al., 1999; Morita
et al., 2001), these studies were completed under standard labora-
tory growth conditions (i.e., using planktonic cultures), and may
not be applicable to the bioﬁlm conditions. Other have found
that both mexAB-oprM and mexCD-oprJ expression is decreased
in developed bioﬁlms, and that individual bioﬁlms comprised of
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FIGURE 4 | Individual subproteomes have unique antibiotic and
resistance proteins with both redundant and distinct functions. (A–E)
Venn diagrams showing shared and exclusive proteins among growth modes
and sample types. Bioﬁlm sample groups are shown in purple and planktonic
sample groups are shown in orange. Unique proteins for each comparison (if
applicable) are further divided into functional categories with blue pie slices
representing proteins with known roles in antimicrobial resistance (efﬂux and
PCAP-resistance proteins) and green pie slices representing proteins with
known roles in antimicrobial susceptibility (drug targets and
PCAP-susceptibility proteins).
P. aeruginosa stains lacking MexAB-OprM,MexCD-OprJ,MexEF-
OprN, or MexXY did not have altered antibiotic resistance proﬁles
compared towild type controls (DeKievit et al., 2001). In contrast,
the proteins MexG and MexI, of the efﬂux pump MexGHI-OpmD,
were present at higher levels in early bioﬁlm samples (Figure 3A).
This system, ﬁrst identiﬁed in 2002, confers resistance to vanadium
(Aendekerk et al., 2002),whichhas bacteriostatic effect onP. aerug-
inosa cultures under conditions of iron limitation (Baysse et al.,
2000). It was later demonstrated that this pump also plays a role
in the production of quorum sensing molecules (AHL and PQS),
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FIGURE 5 | Protein abundance totals for functional categories
indicate that biofilm OMVs are more distinct than biofilm whole
cells when compared to their planktonic counterparts. Bar graphs
showing the total protein abundance for bioﬁlm (A) and planktonic
(B) whole cell replicate groups in each of the four functional categories
over time. Net whole cell resistance [i.e., (efﬂux + PCAP-resistance
proteins) – (drug targets + PCAP susceptibility proteins)] is shown in
gray. Pie charts showing total protein abundance for each functional
category in matched bioﬁlm (C) and planktonic (D) OMV samples over
time (expressed as a percent of the total abundance). Abbreviations: 24,
24 h; 48, 48 h; 96, 96 h; BV, bioﬁlm OMV; PV, planktonic OMV.
Symbols: *p < 0.05 vs. 24-BV drug targets, **p < 0.05 vs. 48-BV drug
targets, ***p < 0.05 vs. 96-PV drug targets, *****p < 0.05 vs. 48-PV
efﬂux proteins.
and that the mutation of mexI or opmD resulted in decreased,
rather than increased, resistance to a variety of antimicrobials
(Aendekerk, 2005). Consequently, increased abundances in our
samples are likely a result of generalized increases in quorum
sensing activity in the high-cell density environment of bioﬁlm
communities (De Kievit, 2009), and not a bioﬁlm-speciﬁc mech-
anism of resistance. Another protein that was more abundant in
bioﬁlms replicates, PA1874, belongs to an efﬂux pump that has
previously been shown to be involved in bioﬁlm-speciﬁc antibi-
otic resistance (Zhang and Mah, 2008); the gradual decrease
in its abundance over the three time periods (Figure 3A) sug-
gest the role of PA1874 may be less prominent in established
bioﬁlms.
Additional individual whole cell proteins that were signiﬁcantly
more abundant in bioﬁlms include four of the PCAP-R proteins,
namely OprQ (PA2760), NfuA (PA1847), AmgR (PA5200), and
NagZ (PA3005; Figure 3A). These proteins have diverse GO anno-
tations (Winsor et al., 2010), and were increased at various time
points throughout bioﬁlm development; thus, it is likely that they
do not constitute a concerted mechanism of adaptive resistance.
Interestingly, three proteins in the PCAP-R category with roles in
lipid A biosynthesis, speciﬁcally PA0011, ArnA, and ArnB, were
not detected in bioﬁlms (Figure 4B). Modiﬁcation of the lipid A
portion of LPS has been detected in CF isolates of P. aeruginosa
[as described above (Ernst, 1999; Ernst et al., 2005; Cigana et al.,
2009)], can occur in response to environmental stimuli, and is a
www.frontiersin.org September 2014 | Volume 5 | Article 464 | 7
Park et al. Pseudomonas antimicrobial resistance subproteome
recognized strategy for evasion of the innate immune response (for
review see Trent, 2004). Accordingly, recent studies have reported
changes to lipid A structure during P. aeruginosa bioﬁlm growth
in vitro (Ciornei et al., 2010). Although further speculation on the
role of these three proteins in bioﬁlm-speciﬁc resistance is beyond
the scope of this paper, additional MS-based examination of the
large collection of proteins involved in LPS biosynthesis and mod-
iﬁcation (King et al., 2009) during bioﬁlm formation will likely
provide invaluable insight.
In contrast to the whole cells, individual OMV proteins were
almost universally higher in bioﬁlms as compared to planktonic
controls. In addition, as demonstrated in the Figure 4, many
proteins were unique to bioﬁlms OMVs, and no proteins were
exclusively detected in planktonic OMVs (vs. planktonic whole
cells or bioﬁlm OMVs). The reason for this cannot be deter-
mined with the techniques employed in this study, although,
these results suggest that, overall, the bioﬁlm OMV proteome is
enriched in the speciﬁc proteins captured in this focused analysis
of the resistance subproteome. A detailed analysis of the entire
OMV proteome is necessary to determine if this is a global phe-
nomenon. The increased detection of both efﬂux proteins and
porins in the bioﬁlm OMVs is interesting, especially in light of
the recent demonstration that puriﬁed MexB proteins are capable
of drug-transport in artiﬁcial proteoliposomes under an imposed
chemical proton gradient (Welch et al., 2010). The independent
functioning of transport proteins within OMVs has never been
demonstrated.
The examination of individual protein abundances and exclu-
sive pools in both bioﬁlm and planktonic cultures provides
valuable information on speciﬁc targets that may individually
affect the antibiotic resistance. What it fails to capture is the
potential functional outcome of the system. Strikingly, when we
look at each of the four categories in the resistance subproteome
as a whole, we see that none of them are statistically different
in the whole cell cultures. This suggests that there may not be
one clear-cut, bioﬁlm-speciﬁc, protein-based adaptive resistance
mechanism in whole cell P. aeruginosa. Conversely, it suggests
that many subtle changes in the bioﬁlm whole cell proteome may
accumulate to collectively attain high levels of resistance. This
type of effect has been demonstrated for individual genetic muta-
tions, where the combination of several gene deletions, each with
minor effects on resistance, can results in substantial increases
in the concentration of antimicrobials that will effectively inhibit
growth (El’Garch et al., 2007). Alternatively, a major caveat to
our approach is that it does not capture the functional activ-
ity of the proteins in our samples, and it is possible that our
modeling of the functional outcome of the system is overly
simplistic. Combining our current approachwith additional func-
tional studies will further improve our understanding of these
systems.
What can be taken from the systems-based analysis is the sig-
niﬁcantly greater abundance of drug targets in the OMV samples.
Much attention has been paid to the mutation of targets (e.g.,
DNA gyrase and/or topoisomerase) in P. aeruginosa and their
role in ﬂuoroquinolone resistance (for reviews see Neu, 1988;
Hooper and Wolfson, 1989; Piddock, 1999; Ruiz, 2003). Our data,
however, suggest a separate mechanism involving these proteins
that appears to be speciﬁc to bioﬁlms, whereby the targets are
diminished in the whole cell and concentrated in extracellular
structures. The ﬁrst observation (i.e., decreasedwhole cell concen-
trations) is not surprising considering these targets are involved
in core metabolic process (Winsor et al., 2010), and bioﬁlms are
generally considered to be less metabolically active than their
planktonic counterparts.What is unexpected, however, is the iden-
tiﬁcation of 90% of these targets in the bioﬁlm OMVs, and that
many are present at abundance levels similar to the bioﬁlm whole
cells. Importantly, others have shown the aminoglycoside gen-
tamicin bound to the surface of putative OMVs in the process
of formation (Kadurugamuwa et al., 1993); however, the speciﬁc
target it was attaching to was not identiﬁed. One of the pro-
teins we identiﬁed, 30S ribosomal protein S12 (rpsL, PA4268)
is bound by this same class of antibiotics. Importantly, few of
these targets appear in planktonic OMVs, and none appear in the
24 h bioﬁlm OMV replicate group, suggesting that this potential
mechanism of resistance may be speciﬁc to established bioﬁlms.
To determine if this is an active process capable of providing
bioﬁlm-speciﬁc protection from antimicrobials, we require fur-
ther studies to show speciﬁc antimicrobial-drug target interactions
in OMVs, and quantiﬁable contributions to whole cell resistance
are required.
In summary, this study demonstrates the beneﬁt of using MS-
based strategies to study complex systems. Speciﬁcally, we identify
a potential bioﬁlm-speciﬁc adaptive resistance mechanism out-
side of the whole cell, which would have escaped detection using
transcript-based methods such DNA microarray. Furthermore,
we show the effect of individual vs. systems-based analysis on the
interpretation of our data, and laid the groundwork for future
studies that will elucidate strategies to combat highly recalcitrant
microbial bioﬁlms.
MATERIALS AND METHODS
BACTERIAL STRAINS, MEDIA, AND REAGENTS
The parental strain for all studies was P. aeruginosa PAO1. Plank-
tonic cultures were grown in 400 ml of tryptic soy broth (TSB;
BD, Franklin Lakes, NJ, USA) and bioﬁlms were grown on
an equal volume of tryptic soy agar (TSA; BD) solidiﬁed in
a glass dish (190 mm × 100 mm; Corning, Tewksbury, MA,
USA). All reagents, unless otherwise stated, were obtained from
Sigma-Aldrich Canada Co. (Mississauga, ON, Canada).
SAMPLE PREPARATION AND PROTEIN QUANTIFICATION
Sterile TSB andTSAwere inoculatedwith 5ml of overnight culture
normalized to an optical density at 600 nm (OD600) of 3.0. The
inoculum was evenly distributed by gentle agitation (planktonic
cultures) or spread over the agar surface with a sterile glass rod
(bioﬁlm cultures). Three biological replicates of each sample type
were grown statically at 37◦C for 24, 48 or 96 h for a total of 36 indi-
vidual samples. Following incubation, bioﬁlms were scraped off
the TSA with a sterile scoopula and suspended in 400 ml of sterile
TSB.All sampleswere normalized to an optical density (OD600 nm)
of 1.0 before further processing. Whole cells were pelleted by
centrifugation (12,000 × g, 10 min, 4◦C; Avanti J-E, Beckman
Coulter, Pasadena, CA, USA), treated with a protease inhibitor
(Roche Diagnostics, Indianapolis, IN,USA), and stored at −20◦C.
Frontiers in Microbiology | Antimicrobials, Resistance and Chemotherapy September 2014 | Volume 5 | Article 464 | 8
Park et al. Pseudomonas antimicrobial resistance subproteome
The CFS containing the OMVs was retained and processed as
previously described (Murphy et al., 2014). Brieﬂy, the CFS was
subjected to four rounds of ultracentrifugation (50,000 × g, 1.5 h,
4◦C; Beckman L8-55M ultracentrifuge, Beckman Coulter). The
resulting pellet containing the OMVs was washed and resus-
pended in Tris-HCl (pH 8.3), ﬁltered through a 0.45 μm cellulose
acetate membrane syringe ﬁlter (Thermo Scientiﬁc, Ottawa, ON,
Canada), and then sedimented by centrifugation (21,000 × g,
30 min, 4◦C; Eppendorf 5424 microcentrifuge, FA-45-24 rotor,
Mississauga, ON, Canada). The ﬁnal pellet was resuspended in
500 μl of Tris-EDTA (pH 8.3), treated with protease inhibitor
(Roche Diagnostics), and stored at −20◦C until further process-
ing. Prior to enzymatic digestion, whole cell and OMV samples
were sonicated on ice (4 × 15 s with 60 s cooling periods, set-
ting 3, Ultrasonic Processor XL, Misonix Inc., Farmingdale, NY,
USA). Protein yield from the whole cell and OMV samples was
measured using a Micro BCA protein assay kit as per the manu-
facturer’s instructions (Thermo Fisher Scientiﬁc, Waltham, MA,
USA).
PROTEIN DIGESTION
Protein (15 μg) was digested as previously described (Foster
et al., 2003). Brieﬂy, proteins were solubilized in a twofold vol-
ume of denaturation buffer (6 M urea/2 M thiourea in 10 mM
HEPES, pH 8.0), followed by a 30-min treatment with a reduction
buffer (10 mM dithiothritol in a 50 mM ammonium bicarbon-
ate [ABC] buffer), and a 20-min treatment with an alkylation
buffer (55 mM iodoacetamide in 50 mM ABC). Digestion with
0.3 μg Lys C enzyme per sample (3 h) and 0.3 μg trypsin
(16 h; Princeton Separations, Adelphia, NJ, USA) was stopped
by adding 40 μl of 0.1% triﬂuoroacetic acid for every 100 μl
of digestion solution. The resulting peptides were desalted and
concentrated using MonoSpinTM C18 microcolumns as per the
manufacturer’s instructions (GL Sciences, Torrance, CA, USA),
and then lyophilized using a speed vacuum concentrator (Savant
Instruments,Holbrook,NY,USA).The sampleswere reconstituted
in 0.1% formic acid in water prior to analysis.
LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY
(LC-MS/MS)
Liquid chromatography-tandem mass spectrometry (LC-MS/MS)
was completed as previously described (Park et al., 2014). Brieﬂy,
5 μl of tryptic peptides were separated using an EASY-nLC
1000 chromatography system (Thermo Fisher Scientiﬁc, reverse
phase mode, 0.1% formic acid as the mobile phase) paired with
an EASY-Spray ES801 column (75 μm × 50 cm) containing
PepMap RSLC C18 (2 μm) stationary phase (Thermo Fisher Sci-
entiﬁc). Peptides were eluted from the column over 120 min
(including a pre-run equilibration and a post-run wash) using
a 0 to 30% acetonitrile gradient, at a rate of 250 nL/min and
a temperature of 40◦C. Eluted peptides were sprayed directly
into an EASY-Spray integrated emitter (Thermo Fisher Scien-
tiﬁc) for fed nano-electrospray ionization (ESI) using a Q Exactive
hybrid quadrupole-Orbitrap mass spectrometer. Speciﬁcally, a
Q Exactive Orbitrap, a nitrogen-ﬁlled higher-energy dissocia-
tion (HCD) collision cell, and an Orbitrap mass analyzer were
used for parent ion mass measurement, fragmentation, and MS
scans, respectively. Finally, spectrum and peak list generation
were performed using Q Exactive 2.2 and Xcalibur 2.2 (Thermo
Fisher Scientiﬁc) with the following acquisition parameters: MS
resolution 70,000 FWHM, MS/MS resolution 17,500 FWHM,
target 1 × 10e6 ions, 10 MS/MS scans/cycle, 15 s dynamic
exclusion.
DATA ANALYSIS
Raw data ﬁles were extracted and searched against the UniPro-
tKB P. aeruginosa ATCC15692 database (5564 entries) using
MaxQuant (Cox and Mann, 2008) quantitative proteomics soft-
ware (version 1.4.0.5, Max Planck Institute of Biochemistry,
Martinsried, Germany) with the following settings: label-free
quantiﬁcation (LFQ), Trypsin/P digestion, maximum of two
missed cleavages and ﬁve modiﬁcations per peptide, 0.02 Da
fragment ion mass tolerance, and 20.0 PPM parent ion tol-
erance. Variable peptide modiﬁcation included deamidation of
asparagine and glutamine plus oxidation of methionine. Fixed
peptide modiﬁcations included carbamidomethyl alkylation of
cysteine. Modiﬁcations used in protein quantiﬁcation included
acetylation of the n-terminus, and oxidation of methionine. A
false discovery rate (FDR) of 1% was applied for both peptides
and proteins using decoys generated with a reverse ATCC15692
database. MaxQuant results were loaded into Perseus (Max Planck
Institute of Biochemistry) and the LFQ intensity values were
transformed [log2(x)] for downstream bioinformatics (heat maps
and Venn diagrams) and statistics. Statistical analysis for individ-
ual proteins (Figure 3) was completed in Perseus by comparing
growth modes (i.e., bioﬁlm vs. planktonic) within sample type
(i.e., whole cell and OMV) and time point replicate groups
using two-sample Student’s t-test. A permutation-based FDR,
based on 250 randomizations of the data, was used to con-
trol the type I error rate. Statistical analysis of the functional
categories (Figure 5) was completed using Prism (GraphPad
Software Inc., CA, USA). Speciﬁcally, a one-way analysis of vari-
ance (ANOVA) with a Tukey’s post-test was used to compare the
total protein abundance within functional groups between repli-
cate groups. Alpha was set to 0.05 for both the t-test and the
ANOVA. Additional analysis and graphical representation of the
data was completed using Microsoft Excel (Microsoft Corpora-
tion, WA, USA). The information provided herein is compliant
with the Minimum Information about a Proteomics Experi-
ment (MIAPE) Mass Spectrometry Informatics (MIAPE-MSI)
guidelines (Binz et al., 2008).
PROTEIN ANNOTATIONS
Proteins were manually annotated using various methods. Brieﬂy,
“efﬂux”proteins were identiﬁed by performing an advanced search
of the Pseudomonas Genome Database (Winsor et al., 2010) by
selecting “Pseudomonas aeruginosa PAO1,” search ﬁeld “name
(protein/product),” term “efﬂux.” This search returned 39 results;
15 of these proteins were detected in our samples. Three addi-
tional porins,OpmD(Aendekerk et al., 2002),OpmH(Mima et al.,
2007), and OpmB (Mima et al., 2009) were manually identiﬁed as
belonging to multidrug efﬂux systems. “Resistance” and“suscepti-
bility” proteins were identiﬁed using the “browse by Pseudomonas
aeruginosa PAO1 genome project function class” function, found
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under the simple searchmenuof the database (Winsor et al., 2010).
This search returned 70 results; 28 of these proteins were detected
in our samples. Individual proteins were separated into either
resistance or susceptibility based on transposon mutant screens
(Breidenstein et al., 2008; Alvarez-Ortega et al., 2010; Fernandez
et al., 2012), or individual studies as indicated in Table S1 in
Supplementary Materials. Seven of the proteins identiﬁed in this
search, PA1238 (alternately known as OpmJ), PA1874 (Zhang and
Mah, 2008), OprM, MexA, MexB, TriA, and TriB were allocated
to the “efﬂux” protein group. Finally, protein drug targets were
identiﬁed using the browse by “Drugs and their targets” function,
found under the simple search menu of the database (Winsor
et al., 2010). This search returned 12 results (excluding the eight
16S and 23S rRNAs); 10 of these proteins were detected in our
samples.
IMAGING
Bioﬁlms specimens and OMVs were prepared for SEM and trans-
mission electron microscopy (TEM), respectively, as previously
described (Murphy et al., 2014). Brieﬂy, sections of TSA and
overlying bioﬁlm were ﬁxed in 2% glutaraldehyde (30 min) and
osmium tetraoxide (30 min; Canemco Inc., Canton de Gore, QC,
Canada). Samples were dehydrated in a series of ethanol solu-
tions (50–100%), critical point dried, and then coated with 15
nm gold using a K550X sputter coater (Emitech Ltd., Kent, UK).
Images were acquired with a S-570 scanning electron microscope
(Hitachi High Technologies Canada, Inc., Toronto, ON, Canada).
OMVs were whole mounted on carbon-coated 200-mesh copper
grids (Gilder Grids Ltd., Lincolnshire, England), and negatively
stained with 1% uranyl acetate. Images were acquired with a CM-
10 transmission electronmicroscope (Phillips InnovationServices,
Eindhoven, Netherlands), paired with a Morada 11-megapixel
charge-coupled device (CCD) camera (Olympus Soft Imaging
Solutions, Munster, Germany).
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